1. Home
  2. AQST vs MATW Comparison

AQST vs MATW Comparison

Compare AQST & MATW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • MATW
  • Stock Information
  • Founded
  • AQST 2004
  • MATW 1850
  • Country
  • AQST United States
  • MATW United States
  • Employees
  • AQST N/A
  • MATW N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • MATW Metal Fabrications
  • Sector
  • AQST Health Care
  • MATW Telecommunications
  • Exchange
  • AQST Nasdaq
  • MATW Nasdaq
  • Market Cap
  • AQST 809.3M
  • MATW 702.3M
  • IPO Year
  • AQST 2018
  • MATW 1994
  • Fundamental
  • Price
  • AQST $6.99
  • MATW $23.44
  • Analyst Decision
  • AQST Strong Buy
  • MATW
  • Analyst Count
  • AQST 7
  • MATW 0
  • Target Price
  • AQST $10.71
  • MATW N/A
  • AVG Volume (30 Days)
  • AQST 3.6M
  • MATW 197.9K
  • Earning Date
  • AQST 10-31-2025
  • MATW 11-20-2025
  • Dividend Yield
  • AQST N/A
  • MATW 4.32%
  • EPS Growth
  • AQST N/A
  • MATW N/A
  • EPS
  • AQST N/A
  • MATW N/A
  • Revenue
  • AQST $44,132,000.00
  • MATW $1,625,543,000.00
  • Revenue This Year
  • AQST N/A
  • MATW N/A
  • Revenue Next Year
  • AQST $51.50
  • MATW N/A
  • P/E Ratio
  • AQST N/A
  • MATW N/A
  • Revenue Growth
  • AQST N/A
  • MATW N/A
  • 52 Week Low
  • AQST $2.12
  • MATW $18.50
  • 52 Week High
  • AQST $7.55
  • MATW $32.24
  • Technical
  • Relative Strength Index (RSI)
  • AQST 63.34
  • MATW 46.84
  • Support Level
  • AQST $6.78
  • MATW $21.95
  • Resistance Level
  • AQST $7.55
  • MATW $23.41
  • Average True Range (ATR)
  • AQST 0.41
  • MATW 0.73
  • MACD
  • AQST 0.04
  • MATW -0.00
  • Stochastic Oscillator
  • AQST 71.13
  • MATW 33.18

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About MATW Matthews International Corporation

Matthews International Corp is a personal services company that provides brand solution services, memorialization products, and industrial products in the United States and Europe. The majority of Matthews' revenue is derived from its SGK Brand Solutions business, which provides brand development services, printing equipment, creative design services, and embossing tools to the consumer packaged goods and packaging industries. The company's Memorialization segment, which sells bronze and granite memorials, caskets, and cremation equipment to the cemetery and funeral home industries, also contributes an important amount. Maximum amount of Matthews' revenue is generated from sales made in the North America, while European customers also contribute a sizable percentage.

Share on Social Networks: